Publications by authors named "Ballentine Carter"

100Publications

Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial.

Eur Urol 2020 Sep 19;78(3):360-368. Epub 2020 May 19.

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2020.05.001DOI Listing
September 2020

Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance.

BJU Int 2020 06 2;125(6):861-866. Epub 2020 Mar 2.

The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.15033DOI Listing
June 2020

Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer.

Urology 2020 Apr 15;138:84-90. Epub 2020 Jan 15.

Department of Urology, James Buchanan Brady Institute, The Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2020.01.001DOI Listing
April 2020

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.

Eur Urol 2020 Jun 7;77(6):675-682. Epub 2020 Jan 7.

The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.12.017DOI Listing
June 2020

The association between clinically determined periodontal disease and prostate-specific antigen concentration in men without prostate cancer: the 2009-2010 National Health and Nutrition Examination Survey.

Cancer Causes Control 2019 Dec 21;30(12):1293-1300. Epub 2019 Oct 21.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Room E6132, 615 N Wolfe St, Baltimore, MD, 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-019-01238-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858585PMC
December 2019

Legends in Urology.

Can J Urol 2019 10;26(5):9906-9907

Professor of Urology and Oncology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
October 2019

In-office Transperineal Prostate Biopsy Using Biplanar Ultrasound Guidance: A Step-by-Step Guide.

Urology 2019 Nov 30;133:247. Epub 2019 Jul 30.

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.07.021DOI Listing
November 2019

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

Eur Urol Oncol 2019 05 13;2(3):333-336. Epub 2018 Sep 13.

Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311183013
Publisher Site
http://dx.doi.org/10.1016/j.euo.2018.08.017DOI Listing
May 2019

Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.

Cancer Epidemiol Biomarkers Prev 2019 08 3;28(8):1331-1338. Epub 2019 Jun 3.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-19-0145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677604PMC
August 2019

Editorial Comment.

J Urol 2019 05;201(5):922

Johns Hopkins School of Medicine , Baltimore , Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JU.0000554387.61658.afDOI Listing
May 2019

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer.

Eur Urol 2019 05 8;75(5):743-749. Epub 2018 Oct 8.

Program for Personalized Cancer Care, North Shore University Health System, Evanston, IL, USA; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183068
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.09.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699614PMC
May 2019

Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer.

Urology 2018 Nov 30;121:118-124. Epub 2018 Aug 30.

Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00904295183090
Publisher Site
http://dx.doi.org/10.1016/j.urology.2018.08.021DOI Listing
November 2018

Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer-Reply.

JAMA Oncol 2018 08;4(8):1133-1134

The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0754DOI Listing
August 2018

Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.

JAMA 2018 05;319(18):1866-1868

Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.4914DOI Listing
May 2018

Cost implications of PSA screening differ by age.

BMC Urol 2018 May 9;18(1):38. Epub 2018 May 9.

Department of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street, Suite 2-519, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12894-018-0344-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944051PMC
May 2018

Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy.

J Urol 2018 11 17;200(5):1068-1074. Epub 2018 Apr 17.

The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.04.058DOI Listing
November 2018

Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving Practice.

Eur Urol 2018 05 17;73(5):713-714. Epub 2018 Feb 17.

James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.02.006DOI Listing
May 2018

Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.

Urol Oncol 2018 04 26;36(4):158.e7-158.e12. Epub 2017 Dec 26.

The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.12.005DOI Listing
April 2018

Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts.

Ann Intern Med 2018 01 28;168(1):1-9. Epub 2017 Nov 28.

From University of Washington, Seattle, Washington; Fred Hutchinson Cancer Research Center, Seattle, Washington; Technical University of Munich, Garching, Germany; The James Buchanan Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland; University of California, San Francisco, San Francisco, California; University of Toronto, Toronto, Ontario, Canada; and Vanderbilt University, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M17-0548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752581PMC
January 2018

Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.

J Urol 2018 04 24;199(4):954-960. Epub 2017 Oct 24.

Department of Urology, The James Buchanan Brady Urological Institute, Baltimore, Maryland; Department of Pathology (JIE), Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.10.029DOI Listing
April 2018

Active surveillance of prostate cancer: Current state of practice and utility of multiparametric magnetic resonance imaging.

Rev Urol 2017 ;19(2):77-88

The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of MedicineBaltimore, MD.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610357PMC
http://dx.doi.org/10.3909/riu0757aDOI Listing
January 2017

Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Con.

J Urol 2017 11 22;198(5):997-999. Epub 2017 Sep 22.

James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.08.088DOI Listing
November 2017

Informational needs during active surveillance for prostate cancer: A qualitative study.

Patient Educ Couns 2018 02 1;101(2):241-247. Epub 2017 Sep 1.

Department of Population Health, New York University, New York City, USA; Manhattan Veterans Affairs Medical Center, New York City, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2017.08.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808852PMC
February 2018

Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy.

Nat Rev Urol 2018 01 31;15(1):55-66. Epub 2017 Aug 31.

Department of Pathology, Johns Hopkins University School of Medicine, 401 N. Broadway, Weinberg 2242, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2017.134DOI Listing
January 2018

Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group.

JAMA Oncol 2018 Jan;4(1):89-92

The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.1879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833628PMC
January 2018

Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease.

J Urol 2017 09 24;198(3):608-613. Epub 2017 Mar 24.

Department of Urology, The Johns Hopkins University School of Medicine, The James Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.03.122DOI Listing
September 2017

Active Surveillance of Localized Prostate Cancer: Acknowledging Uncertainty.

J Clin Oncol 2016 12 31;34(36):4452. Epub 2016 Oct 31.

Jeffrey J. Tosoian and H. Ballentine Carter, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.8888DOI Listing
December 2016

Editorial Comment.

J Urol 2016 12 15;196(6):1658. Epub 2016 Sep 15.

The James Buchanan Brady Urological Institute, Baltimore, Maryland; Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.06.105DOI Listing
December 2016

Prediction of the Pathologic Gleason Score to Inform a Personalized Management Program for Prostate Cancer.

Eur Urol 2017 07 11;72(1):135-141. Epub 2016 Aug 11.

The Johns Hopkins University School of Medicine, The James Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.08.005DOI Listing
July 2017

Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance.

BJU Int 2017 07 29;120(1):25-31. Epub 2016 Aug 29.

The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13608DOI Listing
July 2017

Optimizing Active Surveillance.

Eur Urol 2016 12 22;70(6):909-911. Epub 2016 Jul 22.

The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.07.017DOI Listing
December 2016

The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.

Eur Urol 2017 02 25;71(2):174-180. Epub 2016 May 25.

The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.05.021DOI Listing
February 2017

Improving Prostate Cancer Screening and Diagnosis: Health Policy and Biomarkers Beyond PSA.

JAMA Oncol 2016 Jul;2(7):867-8

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0170DOI Listing
July 2016

Active surveillance for prostate cancer: current evidence and contemporary state of practice.

Nat Rev Urol 2016 Apr 8;13(4):205-15. Epub 2016 Mar 8.

Department of Urology, New York University, 550 1st Avenue (VZ30 #612), New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2016.45DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940050PMC
April 2016

Reply to M.C. Scholz et al.

J Clin Oncol 2016 Apr 16;34(11):1284. Epub 2016 Feb 16.

Johns Hopkins School of Medicine, Baltimore, MD

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9755DOI Listing
April 2016

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report.

Urol Case Rep 2015 Sep 15;3(5):175-7. Epub 2015 Jul 15.

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eucr.2015.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672671PMC
September 2015

Reply.

Urology 2015 Nov;86(5):997

The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://mearsheimer.uchicago.edu/pdfs/A0022.pdf
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S009042951500811
Publisher Site
http://dx.doi.org/10.1016/j.urology.2015.07.044DOI Listing
November 2015

Magnetic Resonance-Guided Prostate Biopsy.

Magn Reson Imaging Clin N Am 2015 Nov 9;23(4):621-31. Epub 2015 Jul 9.

The Russell H. Morgan Department of Radiology and Radiological Science, The James Buchanan Brady Urological Institute, The Johns Hopkins University, 601 North Caroline Street, JHOC 3140C, Baltimore, MD 21287, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mric.2015.05.005DOI Listing
November 2015

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery.

Eur Urol 2016 Apr 9;69(4):576-581. Epub 2015 Oct 9.

The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.09.032DOI Listing
April 2016

Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.

Can J Urol 2015 Oct;22(5):7965-72

The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
October 2015

A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.

Cancer Epidemiol Biomarkers Prev 2015 Dec 24;24(12):1864-72. Epub 2015 Sep 24.

The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755280PMC
December 2015

Predictors of Adverse Pathology in Men Undergoing Radical Prostatectomy Following Initial Active Surveillance.

Urology 2015 Nov 31;86(5):991-5. Epub 2015 Aug 31.

The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2015.07.039DOI Listing
November 2015

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.

J Clin Oncol 2015 Oct 31;33(30):3379-85. Epub 2015 Aug 31.

All authors: The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.5764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863946PMC
October 2015

The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind?

Int Braz J Urol 2015 Jan-Feb;41(1):10-4

1Department of Urology, Johns Hopkins Hospital, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752051PMC
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.01.03DOI Listing
August 2015

Variability in Medicare utilization and payment among urologists.

Urology 2015 May 4;85(5):1045-1051. Epub 2015 Mar 4.

Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.11.054DOI Listing
May 2015

Active surveillance for favorable risk prostate cancer.

Curr Opin Urol 2015 May;25(3):230-1

Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000167DOI Listing
May 2015

Radical Prostatectomy Findings in Men on Active Surveillance: Variable Findings Dependent on Reason for Surgery and Entry Criteria.

J Urol 2015 Sep 25;194(3):685-9. Epub 2015 Feb 25.

Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland; Department of Urology, The Johns Hopkins Hospital, Baltimore, Maryland; Department of Oncology, The Johns Hopkins Hospital, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.02.085DOI Listing
September 2015

Aligning evidence and practice: future research needs to increase utilization of active surveillance for favorable risk prostate cancer.

Curr Opin Urol 2015 May;25(3):277-82

Department of Urology, Johns Hopkins University School of Medicine, James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000153DOI Listing
May 2015

Conditional probability of reclassification in an active surveillance program for prostate cancer.

J Urol 2015 Jun 6;193(6):1950-5. Epub 2015 Jan 6.

The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2014.12.091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696016PMC
June 2015

Robotic surgery in urological oncology: patient care or market share?

Nat Rev Urol 2015 01 23;12(1):55-60. Epub 2014 Dec 23.

Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, 600 North Wolfe Street, Marburg 409, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2014.339DOI Listing
January 2015

Reply: To PMID 25440986.

Urology 2015 Jan 16;85(1):154. Epub 2014 Oct 16.

James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.06.089DOI Listing
January 2015

Re: Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening.

J Urol 2015 Mar 1;193(3):1063-4; discussion 1064. Epub 2014 Dec 1.

Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2014.09.114DOI Listing
March 2015

Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes.

Urology 2015 Jan 16;85(1):147-53. Epub 2014 Oct 16.

Russell H. Morgan Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD; James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.06.085DOI Listing
January 2015

Reclassification rates are higher among African American men than Caucasians on active surveillance.

Urology 2015 Jan 14;85(1):155-60. Epub 2014 Oct 14.

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.08.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275346PMC
January 2015

Do environmental factors modify the genetic risk of prostate cancer?

Cancer Epidemiol Biomarkers Prev 2015 Jan 23;24(1):213-20. Epub 2014 Oct 23.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Brady Urological Institute and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0786-TDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337874PMC
January 2015

Practice patterns and individual variability of surgeons performing radical prostatectomy at a high volume academic center.

J Urol 2015 Mar 6;193(3):812-9. Epub 2014 Sep 6.

The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2014.08.101DOI Listing
March 2015

Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis.

J Urol 2015 Feb 9;193(2):552-6. Epub 2014 Aug 9.

The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2014.08.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332776PMC
February 2015

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.

Arch Pathol Lab Med 2014 Oct 5;138(10):1387-405. Epub 2014 Aug 5.

From the Departments of Pathology and Laboratory Medicine (Drs Amin and Knudsen), Radiation Oncology (Dr Sandler), Urology (Dr Holden), and Biomedical Sciences (Dr Knudsen), Cedars-Sinai Medical Center, Los Angeles, California; the Departments of Urology (Drs Lin and Gore) and Pathology (Dr True), University of Washington, Seattle; Trillium Health Partners, Mississauga, Ontario, Canada, and McMaster University, Hamilton, Ontario, Canada (Dr Srigley); Aquesta Pathology, Toowong, Queensland, Australia, and the University of Queensland, Brisbane (Dr Samaratunga); the Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden (Dr Egevad); the Institute for Precision Medicine and the Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, Ithaca, New York, and New York-Presbyterian Hospital, New York (Dr Rubin); the Departments of Surgery (Dr Nacey) and Pathology and Molecular Medicine (Dr Delahunt), Wellington School of Medicine and Health Sciences, University of Otago, Newtown, Wellington, New Zealand; the James Buchanan Brady Urological Institute (Dr Carter) and the Departments of Pathology (Dr Epstein), Urology (Dr Epstein), and Oncology (Dr Epstein), Johns Hopkins School of Medicine, Baltimore, Maryland; Division of Urology, the Sunnybrook Health Sciences Centre (Dr Klotz) and the University Health Network (Dr Evans), University of Toronto, Toronto, Ontario, Canada; the Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston (Dr Zietman); the Section of Pathological Anatomy, Department of Biomedical Sciences and Public Health, Polytechnic University of the Marche Region, Ancona, Italy (Dr Montironi); the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (Dr Humphrey); the Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio (Dr McKenney); the Department of Cell

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0219-SADOI Listing
October 2014

Reducing prostate cancer deaths: unsupported speculation about the androgen deprivation hypothesis.

Eur Urol 2014 Dec 10;66(6):973-4. Epub 2014 Jul 10.

James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.06.051DOI Listing
December 2014

Multiparametric MRI findings of granulomatous prostatitis after intravesical bacillus Calmette-Guérin therapy in a patient undergoing active surveillance.

Clin Genitourin Cancer 2014 Oct 10;12(5):e215-9. Epub 2014 Jun 10.

Russell H. Morgan Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD; James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.03.015DOI Listing
October 2014

Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program.

Patient 2014 ;7(4):427-36

Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40271-014-0066-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332784PMC
February 2015

Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study.

Reg Anesth Pain Med 2014 Jul-Aug;39(4):284-8

From the *Department of Anesthesiology, The Mount Sinai Medical Center, New York, NY; Departments of †Anesthesiology and ‡Urology, The Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AAP.0000000000000108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096680PMC
February 2015

Multiparametric magnetic resonance imaging (MRI) and active surveillance for prostate cancer: future directions.

BJU Int 2014 Jun;113(6):844-5

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.12473
Publisher Site
http://dx.doi.org/10.1111/bju.12473DOI Listing
June 2014

Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols.

BJU Int 2015 Feb 16;115(2):216-22. Epub 2014 Aug 16.

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12828DOI Listing
February 2015

Biopsy criteria for determining appropriateness for active surveillance in the modern era.

Urology 2014 Apr;83(4):869-74

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD; Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, MD; Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.12.054DOI Listing
April 2014

Diagnostic challenges of clonal heterogeneity in prostate cancer.

J Clin Oncol 2015 Mar 17;33(7):e38-40. Epub 2014 Mar 17.

Sidney Kimmel Comprehensive Cancer Center; and Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.3540DOI Listing
March 2015

Overdiagnosis and overtreatment of prostate cancer.

Eur Urol 2014 Jun 9;65(6):1046-55. Epub 2014 Jan 9.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.12.062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113338PMC
June 2014

Value of transition zone biopsy in active surveillance of prostate cancer.

J Urol 2014 Jun 5;191(6):1755-9. Epub 2013 Dec 5.

Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland; Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, Maryland; Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.11.058DOI Listing
June 2014

Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassification.

J Comput Assist Tomogr 2013 Nov-Dec;37(6):948-56

From the *Russell H. Morgan Department of Radiology, †James Buchanan Brady Urological Institute, and ‡Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0b013e31829ae20aDOI Listing
January 2014

Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.

J Urol 2014 Mar 20;191(3):629-37. Epub 2013 Sep 20.

James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.09.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711358PMC
March 2014

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

BJU Int 2013 Sep;112(5):543-7

The Johns Hopkins University School of Medicine, Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.12318
Publisher Site
http://dx.doi.org/10.1111/bju.12318DOI Listing
September 2013

Prostate volumetric assessment by magnetic resonance imaging and transrectal ultrasound: impact of variation in calculated prostate-specific antigen density on patient eligibility for active surveillance program.

J Comput Assist Tomogr 2013 Jul-Aug;37(4):589-95

The Russell H. Morgan Department of Radiology Radiological Science, The Johns Hopkins University, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0b013e318296af5fDOI Listing
September 2013

Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer.

Urol Oncol 2014 Jan 17;32(1):39.e1-10. Epub 2013 Jun 17.

The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, Baltimore, MD; The James Buchanan Brady Urological Institute, The Johns Hopkins University, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2013.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991164PMC
January 2014

Prostate-specific antigen-based screening for prostate cancer: the irony of it all.

Eur Urol 2013 Nov 12;64(5):710-1; discussion 711-2. Epub 2013 Jun 12.

Department of Urology, Marburg 145, Johns Hopkins Hospital, 600N. Wolfe Street, Baltimore, MD 21287-2101, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.06.004DOI Listing
November 2013

Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.

BJU Int 2014 Apr 7;113(4):561-7. Epub 2013 Jun 7.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine; Horten Center for patient orientated research and knowledge transfer, University of Zurich; Department of Urology, University of Zurich, University Hospital, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978167PMC
April 2014

Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis.

J Urol 2013 Dec 13;190(6):2033-8. Epub 2013 May 13.

James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.05.015DOI Listing
December 2013

Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance.

J Urol 2013 Oct 30;190(4):1218-22. Epub 2013 Apr 30.

Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.04.071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978170PMC
October 2013

Point: Impact of prostate-specific antigen velocity on management decisions and recommendations.

J Natl Compr Canc Netw 2013 Mar;11(3):281-5

Department of Urology, New York University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0039DOI Listing
March 2013

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

J Urol 2013 Jun 26;189(6):2039-46. Epub 2013 Feb 26.

Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.02.072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925148PMC
June 2013